EU says COVID boosters may have higher legal risks without EMA approval
The Peninsula
BRUSSELS: European Union countries that decide to use COVID-19 vaccine booster shots may face increased legal risks because the additional dose has not yet been recommended by the EU drugs regulator, the European Commission said on Thursday.
The European Medicines Agency (EMA) has repeatedly said that more data is needed before it can approve the use of boosters, but eight European countries have decided to recommend the additional dose, and more than a dozen are set to make similar moves shortly. "Booster doses are currently not part of the marketing authorisation of COVID-19 vaccines and have not yet been subject to a scientific assessment by EMA in the absence of sufficient data," the EU Commission said in a statement to Reuters on Thursday.More Related News